MARC record from Internet Archive

LEADER: 02740cam a2200409Ia 4500
001 8931520
005 20190121130622.0
008 110304s2011 dcua b 100 0 eng d
020 $a0309163218
020 $a9780309163217
035 $a(OCoLC)ocn705518868
035 $a(OCoLC)705518868
035 $a(NNC)8931520
040 $aYDXCP$cYDXCP$dNRZ
090 $aR857.N34$bN375 2011
245 00 $aNanotechnology and oncology :$bworkshop summary /$cMargie Patlak and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.
260 $aWashington,D.C. :$bNational Academies Press,$cc2011
300 $axii, 106 p. :$bill. ;$c23 cm.
504 $aIncludes bibliographical references (p.69-71).
520 $a"One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts."--Publisher's Website.
530 $aAlso available online.
650 0 $aNanomedicine$vCongresses.
650 0 $aOncology$xResearch$zUnited States$vCongresses.
650 0 $aNanotechnology, Experimental$vCongresses.
650 0 $aCancer$xTreatment$vCongresses.
650 12 $aNanomedicine.
655 2 $aCongress.
650 22 $aMedical Oncology.
651 2 $aUnited States.
650 22 $aNanotechnology.
650 22 $aNeoplasms, Second Primary.
700 1 $aPatlak, Margie.
700 1 $aMicheel, Christine.
710 2 $aInstitute of Medicine (U.S.).$bPlanning Committee on Policy Issues in Nanotechnology and Oncology.
710 2 $aNational Cancer Policy Forum (U.S.)
856 41 $uhttp://www.nap.edu/catalog.php?record_id=13037
852 00 $boff,hsl$hR857.N34$iN375 2011